EcoDrugPlus

Ribosomal Protein L10a

Ensembl ID : ENSCHAG00000020440
Gene Symbol: RPL10A
3 Cross references
377 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSCHAG00000015580
Gene Symbol: RPL11
3 Cross references
287 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSCHAG00000005485
Gene Symbol: RPL12
3 Cross references
490 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSCHAG00000005404
Gene Symbol: RPL14
3 Cross references
311 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSCHAG00000016257
Gene Symbol: RPL15
3 Cross references
376 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSCHAG00000010742
Gene Symbol: RPL17
3 Cross references
325 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSCHAG00000022298
Gene Symbol: RPL18
3 Cross references
380 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSCHAG00000004152
Gene Symbol: RPL18A
3 Cross references
366 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSCHAG00000016644
Gene Symbol: RPL19
3 Cross references
345 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSCHAG00000004087
Gene Symbol: RPL19
3 Cross references
350 Possible Orthologues:

Ribosomal Protein L23a

Ensembl ID : ENSCHAG00000020512
Gene Symbol: RPL23A
3 Cross references
821 Possible Orthologues:

Ribosomal Protein L26 Like 1

Ensembl ID : ENSCHAG00000018807
Gene Symbol: RPL26L1
3 Cross references
477 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).